Crossmark

Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview

Crossref DOI link: https://doi.org/10.1007/s10689-017-0024-8

Published Online: 2017-07-14

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Farag, S. https://orcid.org/0000-0002-1634-5033
van der Kolk, L. E.

van Boven, H. H.

van Akkooi, A. C. J.

Beets, G. L.

Wilmink, J. W.

Steeghs, N.
Funding

Funding for this research was provided by:

Novartis Pharma

Pfizer

Bayer
License Information

License valid from 2017-07-14

Document is current

Any future updates will be listed below